Tokai Pharmaceuticals

Ablaze Pharmaceuticals is part of Vivo Capital's portfolio, focusing on innovative healthcare solutions.

#Pharmaceuticals

Aligos Therapeutics is involved in developing therapies for liver diseases and viral infections.

#Biopharmaceuticals

Actelion focuses on innovative treatments for pulmonary arterial hypertension.

#Biopharmaceuticals

Lepu Biopharma focuses on oncology therapeutics and successfully listed on the HKEX.

#Biopharmaceuticals

Lepu ScienTech focuses on interventional medical devices for structural heart disease and has a significant market share in China.

#Medical Technology

Zogenix was acquired by UCB, focusing on therapies for rare diseases.

#Biopharmaceuticals

Zenas BioPharma is a clinical-stage company focused on immunology-based therapies.

#Biopharmaceuticals

Instil Bio is involved in licensing agreements for innovative cancer therapies.

#Biopharmaceuticals

Verona Pharma received FDA approval for Ohtuvayre, a treatment for COPD.

#Pharmaceuticals

Ronovo Surgical focuses on surgical robotics and has raised $44M in Series B financing.

#Medical Technology

Geron Corporation received FDA approval for RYTELO, a treatment for blood cancer.

#Biopharmaceuticals

Ajax Therapeutics is advancing a JAK2 inhibitor for myelofibrosis treatment.

#Biopharmaceuticals

Soleno Therapeutics received FDA Breakthrough Therapy Designation for DCCR in PWS.

#Biopharmaceuticals

Vertex Pharmaceuticals acquired Alpine Immune Sciences for $4.9 billion.

#Biopharmaceuticals

Gilead Sciences completed the acquisition of CymaBay Therapeutics.

#Biopharmaceuticals

GSK completed the acquisition of BELLUS Health, focusing on chronic cough treatments.

#Biopharmaceuticals

Lilly acquired DICE Therapeutics to advance innovation in immunology.

#Biopharmaceuticals

AstraZeneca acquired CinCor Pharma to strengthen its cardiorenal pipeline.

#Biopharmaceuticals

ScienTech Medical Technology successfully listed on the Hong Kong Stock Exchange.

#Medical Technology

Pfizer completed the acquisition of Biohaven Pharmaceuticals.

#Biopharmaceuticals

AMGEN acquired ChemoCentryx for $4 billion in cash.

#Biopharmaceuticals

Arcutis Biotherapeutics received FDA approval for ZORYVE cream for plaque psoriasis.

#Biopharmaceuticals

GSK reached an agreement to acquire Sierra Oncology for $1.9 billion.

#Biopharmaceuticals

Legend Biotech received FDA approval for CARVYKTI, a CAR-T therapy.

#Biotechnology

AstraZeneca completed the acquisition of Icosavax, focusing on innovative vaccines.

#Biopharmaceuticals

Iovance Biotherapeutics received FDA accelerated approval for AMTAGVI for melanoma.

#Biotechnology

Bristol Myers Squibb completed the acquisition of Mirati Therapeutics.

#Biopharmaceuticals

Avistone Biotechnology focuses on precision oncology therapeutics.

#Biotechnology

Inspirna partnered with Merck KGaA to accelerate global development of Ompenaclid.

#Biopharmaceuticals

AstraZeneca acquired Gracell Biotechnologies to further cell therapy ambitions.

#Biotechnology

Novartis completed the acquisition of Chinook Therapeutics for kidney disease treatments.

#Biopharmaceuticals

EpiBiologics focuses on antibody-based protein degradation platforms.

#Biotechnology

Astellas completed the acquisition of Iveric Bio, focusing on ophthalmology.

#Biopharmaceuticals